Open
525.00
Prev. Close
523.85
Total Traded Value
5.98 Cr
Market Cap (in crs)
2,412.52
Face Value
10
Turnover (in lacs)
598.01
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
Mar 2025 | Dec 2024 | Mar 2024 | Dec 2023 |
---|---|---|---|
114.21 Cr | 103.02 Cr | 214.52 Cr | 78.7 Cr |
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
---|---|---|---|
417.51 Cr | 217.34 Cr | 39.02 Cr | 14.63 Cr |
Mar 2025 | Dec 2024 | Mar 2024 | Dec 2023 |
---|---|---|---|
17.97 Cr | 16.43 Cr | 32.7 Cr | 7.12 Cr |
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
---|---|---|---|
58.34 Cr | 32.71 Cr | 8.43 Cr | 0.99 Cr |
Senores Pharmaceuticals Ltd reported a 100.9% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a - of -.
Its expenses for the quarter were up by 119.4% QoQ and - - YoY.
The net profit increased 99.0% QoQ and - - YoY.
The earnings per share (EPS) of Senores Pharmaceuticals Ltd stood at 12.2 during Q4FY25.
Data Source: BSE, Company announcements
The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.
Period | Combined Delivery Volume | NSE+BSE Traded Volume |
---|---|---|
Day Rs | 44571 Rs | 110409 Rs |
Week Rs | 65799 Rs | 140163 Rs |
Month Rs | 98492 Rs | 220732 Rs |
Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
284.00 | 2,623.53 | 190 | 387.55 | 284.40 | -0.07% | 16.97% | -13.87% | -13.19% | -22.34% | 0.07% | 0.00 | 41.49 | 2.37 | |
92.72 | 2,599.19 | 57.5 | 107.54 | 88.55 | 6.18% | 7.10% | 12.73% | 12.62% | 39.69% | 0.90% | 25.76 | 41.49 | 1.54 | |
233.50 | 2,054.07 | 176.05 | 398 | 231.70 | -7.08% | -10.66% | -0.72% | 0.92% | 203.17% | 0.17% | 30.02 | 41.49 | 3.05 | |
2,512.78 | 744.95 | 1248 | 1,017.70 | 0.99% | 4.31% | 6.78% | -7.42% | 63.60% | 2.46% | 24.90 | 41.49 | 3.20 | ||
550.50 | 2,384.51 | 442.8 | 882.8 | 534.35 | 5.95% | 15.38% | -16.70% | 21.39% | 57.54% | 0.00% | 0.00 | 41.49 | 1.77 | |
55.53 | 2,084.83 | 34 | 69.89 | 54.56 | 2.12% | 28.34% | 9.29% | -9.94% | 126.05% | 0.00% | 43.63 | 41.49 | 3.72 |
As of 24 Jun, 2025, Senores Pharmaceuticals share price is ₹530.8. The stock opened at ₹525 and had closed at ₹523.8 the previous day. During today’s trading session, Senores Pharmaceuticals share price moved between ₹522.10 and ₹536.00, with an average price for the day of ₹529.05. Over the last 52 weeks, the stock has recorded a low of ₹435.25 and a high of ₹665.00. In terms of performance, Senores Pharmaceuticals share price has increased by 35.8% over the past six months and has declined by 8.52% over the last year.
Senores Pharmaceuticals share price is ₹531.35 in NSE and ₹531.2 in BSE as on 24/6/2025.
Senores Pharmaceuticals share price in the past 1-year return was 0. The Senores Pharmaceuticals share hit a 1-year low of Rs. 435.25 and a 1-year high of Rs. 665.
The market cap of Senores Pharmaceuticals is Rs. 2412.52 Cr. as of 24/6/2025.
The PE ratios of Senores Pharmaceuticals is 0 as of 24/6/2025.
The PB ratios of Senores Pharmaceuticals is 3.4 as of 24/6/2025
The Mutual Fund Shareholding in Senores Pharmaceuticals was 3.23% at the end of 24/6/2025.
You can easily buy Senores Pharmaceuticals shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
Please be aware that Senores Pharmaceuticals stock prices are subject to continuous fluctuations due to various factors.